4-Benzyl-3-[(2-methylphenoxy)methyl]-5-methylsulfanyl-1,2,4-triazole

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 4-Benzyl-3-[(2-methylphenoxy)methyl]-5-methylsulfanyl-1,2,4-triazole
• 化学式: C₁₈H₁₉N₃OS
• 分子量: 325.4
• InChiKey: KQEXBAIRDQVNND-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  65.2
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• MANUFACTURE OF 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID
  申请人：ARDEA BIOSCIENCES, INC.

  公开号：US20160214947A1

  公开（公告）日：2016-07-28

  Described herein are certain processes for the synthesis of compounds of Formula (I):

  本文描述了一些合成式(I)化合物的过程：
• Certain triazole-based compounds, compositions, and uses thereof
  申请人：Hodge Nicholas Carl

  公开号：US20050288347A1

  公开（公告）日：2005-12-29

  Thiotriazole-based chemical entities exhibiting ATP-utilizing enzyme inhibitory activity, methods of using such chemical entities, and compositions comprising such chemical entities, are described.

  描述了具有 ATP 利用酶抑制活性的硫代三唑类化学实体、使用此类化学实体的方法以及包含此类化学实体的组合物。
• TREATMENT OF GOUT AND HYPERURICEMIA
  申请人：Miner Jeffrey

  公开号：US20130178484A1

  公开（公告）日：2013-07-11

  Sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetate is described. In addition, pharmaceutical compositions and uses of such compositions for the treatment of a variety of diseases and conditions are described.
• Polymorphic Forms of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-yl)-4H-1,2,4-Triazol-3-ylthio)Acetic Acid and Uses Thereof
  申请人：Ardea Biosciences, Inc.

  公开号：US20190111028A1

  公开（公告）日：2019-04-18

  Crystalline polymorph forms of 2-(5-bromo-4-(4-cyclopropyl naphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid are described. Pharmaceutical compositions and the uses of such compounds, compound forms, and compositions for the treatment of a variety of diseases and conditions are also presented.
• US9216179B2
  申请人：——

  公开号：US9216179B2

  公开（公告）日：2015-12-22